Welcome to LookChem.com Sign In|Join Free
  • or
5-Bromomethyl-2-fluorobenzoic acid is an organic compound characterized by the presence of a bromomethyl group at the 5th position and a fluorine atom at the 2nd position on a benzoic acid backbone. This unique molecular structure endows it with specific chemical properties and potential applications in various fields.

773100-76-8

Post Buying Request

773100-76-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

773100-76-8 Usage

Uses

Used in Pharmaceutical Industry:
5-Bromomethyl-2-fluorobenzoic acid is used as an aminocarboxymuconate semialdehyde decarboxylase inhibitor for its ability to modulate the activity of this enzyme. This makes it a potential candidate for the development of drugs targeting metabolic pathways and conditions where the inhibition of aminocarboxymuconate semialdehyde decarboxylase can be therapeutically beneficial.

Check Digit Verification of cas no

The CAS Registry Mumber 773100-76-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,3,1,0 and 0 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 773100-76:
(8*7)+(7*7)+(6*3)+(5*1)+(4*0)+(3*0)+(2*7)+(1*6)=148
148 % 10 = 8
So 773100-76-8 is a valid CAS Registry Number.

773100-76-8Downstream Products

773100-76-8Relevant academic research and scientific papers

Five-membered or six-membered heterocyclic pyrimidine compound and applications thereof

-

Paragraph 0391-0398, (2020/05/08)

The invention relates to a five-membered or six-membered heterocyclic pyrimidine compound for treating diseases responsive to activation of a TLR7 receptor, and a pharmaceutical composition.

OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS

-

Page/Page column 47, (2018/07/29)

The present invention is related to a compound represented by the following structural formula: The present invention is also related a method of treating a subject with a disease which can be ameliorated by inhibition of aminocarboxymuconate semialdehyde decarboxylase (ACMSD).

Design, synthesis and identification of novel colchicine-derived immunosuppressant

Chang, Dong-Jo,Yoon, Eun-Young,Lee, Geon-Bong,Kim, Soon-Ok,Kim, Wan-Joo,Kim, Young-Myeong,Jung, Jong-Wha,An, Hongchan,Suh, Young-Ger

scheme or table, p. 4416 - 4420 (2010/04/05)

Synthesis and biological evaluation of various colchicine analogues through the mixed-lymphocyte reaction (MLR), lymphoproliferation, and inhibitory effects on the inflammatory genes are described. In addition, a new series of immunosuppressive agents developed on the structural basis of colchicine, as well as their structure-activity relationships is reported. The most potent analogue 20a exhibited an excellent immunosuppressive activity on in vivo skin-allograft model, which is comparable to that of cyclosporin A.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 773100-76-8